We are live on
!
Find out more
CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.67B
1-Year Est. Return
89%
This Fund
S&P 500
This Quarter
Est. Return
+9.19%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$709M
AUM Growth
-$77.6M
(-9.9%)
Cap. Flow
-$116M
Cap. Flow
% of AUM
-16.41%
Top 10 Holdings %
Top 10 Hldgs %
37.25%
Holding
452
New
12
Increased
91
Reduced
283
Closed
40
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$8.04M |
| 2 |
Applied Materials
AMAT
|
+$4.9M |
| 3 |
Amphenol
APH
|
+$4.75M |
| 4 |
Arista Networks
ANET
|
+$4.46M |
| 5 |
Alibaba
BABA
|
+$4.45M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$7.54M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$7.04M |
| 3 |
Adobe
ADBE
|
+$6.93M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$6.31M |
| 5 |
Gilead Sciences
GILD
|
+$4.76M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 43.87% |
| 2 | Healthcare | 22.25% |
| 3 | Consumer Discretionary | 12.69% |
| 4 | Communication Services | 10.44% |
| 5 | Consumer Staples | 3.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Nautilus Biotechnolgy
NAUT
$114M
| $34.4K | ﹤0.01% |
14,717
-9,359
| -39% | -$24.4K |
|
377
Zentalis Pharmaceuticals
ZNTL
$307M
| $34.1K | ﹤0.01% |
8,343
-5,291
| -39% | -$59.1K |
|
378
Atea Pharmaceuticals
AVIR
$405M
| $32.7K | ﹤0.01% |
9,894
-6,285
| -39% | -$23.4K |
|
|
AMRN
379
Amarin Corp
AMRN
$297M
| $32.3K | ﹤0.01% |
2,348
-1,361
| -37% | -$23.4K |
|
380
Align Technology
ALGN
$12.4B
| $32.1K | ﹤0.01% |
133
| – | – |
|
381
MeiraGTx Holdings
MGTX
$1.2B
| $31.8K | ﹤0.01% |
7,556
-4,690
| -38% | -$23.7K |
|
|
RVNC
382
DELISTED
Revance Therapeutics, Inc.
RVNC
| $31.5K | ﹤0.01% |
12,271
-4,710
| -28% | -$16.1K |
|
383
MacroGenics
MGNX
$256M
| $31.3K | ﹤0.01% |
7,357
-4,578
| -38% | -$44.6K |
|
|
EXAI
384
DELISTED
Exscientia Plc American Depositary Shares
EXAI
| $29.4K | ﹤0.01% |
5,755
-3,519
| -38% | -$17.4K |
|
385
uniQure
QURE
$3.13B
| $28.8K | ﹤0.01% |
6,430
-3,492
| -35% | -$17K |
|
386
AtaiBeckley Inc
ATAI
$2.68B
| $26.2K | ﹤0.01% |
19,666
-12,233
| -38% | -$22K |
|
387
Deckers Outdoor
DECK
$12.4B
| $24.2K | ﹤0.01% |
150
-3,900
| -96% | -$600K |
|
388
Edwards Lifesciences
EW
$53.6B
| $23.6K | ﹤0.01% |
256
| – | – |
|
389
Coherus Oncology
CHRS
$181M
| $23.3K | ﹤0.01% |
13,479
-7,947
| -37% | -$16K |
|
|
BLUE
390
DELISTED
bluebird bio
BLUE
| $22K | ﹤0.01% |
1,118
-711
| -39% | -$14.2K |
|
|
VTYX
391
DELISTED
Ventyx Biosciences
VTYX
| $19.1K | ﹤0.01% |
8,282
-3,103
| -27% | -$12.9K |
|
392
Biomea Fusion
BMEA
$92.8M
| $19K | ﹤0.01% |
4,223
-2,639
| -38% | -$26.8K |
|
393
Charles River Laboratories
CRL
$13.6B
| $18.4K | ﹤0.01% |
89
| – | – |
|
394
IQVIA
IQV
$39.8B
| $17.8K | ﹤0.01% |
84
| – | – |
|
395
Caribou Biosciences
CRBU
$169M
| $17.4K | ﹤0.01% |
10,612
-6,412
| -38% | -$20.5K |
|
396
Amylyx Pharmaceuticals
AMLX
$2.6B
| $15.2K | ﹤0.01% |
7,990
-5,014
| -39% | -$9.72K |
|
|
ME
397
DELISTED
23andMe Holding Co
ME
| $14.9K | ﹤0.01% |
1,901
-1,132
| -37% | -$10.8K |
|
398
Repligen
RGEN
$9.35B
| $14.5K | ﹤0.01% |
115
| – | – |
|
|
RAPT
399
DELISTED
RAPT Therapeutics
RAPT
| $12.5K | ﹤0.01% |
513
-312
| -38% | -$14.4K |
|
400
Aclaris Therapeutics
ACRS
$860M
| $9.21K | ﹤0.01% |
8,372
-5,255
| -39% | -$6.17K |
|
Similar funds
HA
JPM
CPO
LCI
GWM
JIP
RMC
GACM
China Universal Asset Management Company's Q2 2024 Portfolio in Review
As of Q2 2024, China Universal Asset Management Company held 452 positions worth $709M, down 9.9% from $787M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
China Universal Asset Management Company withdrew a net $116M in Q2 2024, closing 40 positions and reducing 283 holdings. Its most notable exit was Super Micro Computer, an estimated $4.04M position sold in full.
By sector, the portfolio is most concentrated in Technology at 44% of assets, up from 37% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, China Universal Asset Management Company opened a new position in Arista Networks worth $5.26M.
- China Universal Asset Management Company's largest Q2 2024 buy was Arista Networks: 60,000 shares worth $5.26M.
- China Universal Asset Management Company added most to Apple in Q2 2024, an estimated $8.04M increase.
- China Universal Asset Management Company's biggest Q2 2024 reduction was Amgen, cutting an estimated $7.54M.
- China Universal Asset Management Company fully exited Super Micro Computer in Q2 2024, selling an estimated $4.04M.
- China Universal Asset Management Company's ten largest holdings make up 37% of its $709M portfolio in Q2 2024.
- China Universal Asset Management Company opened 12 new positions and closed 40 in Q2 2024.
- China Universal Asset Management Company's portfolio value fell 9.9% quarter-over-quarter to $709M.
Based on China Universal Asset Management Company's 13F filing for Q2 2024, filed 19 Jul 2024.